While many states have granted permission for health-related marijuana use, it remains classified being a Plan one drug beneath federal benchmarks, missing acknowledged health care apps and posing an important threat of abuse. Furthermore, According to the American Modern society of Clinical Oncology's 2017 pointers, there is insufficient proof